USE OF MARIZOMIB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS

• 收藏
• 分享

专利权人:

Celgene Tri A Holdings Ltd.

发明人:

Mohit Trikha,Ann MacLaren,Nancy Levin

申请号：

US15611614

公开号：

US20170348284A1

申请日:

2017.06.01

申请国别(地区):

US

年份:

2017

代理人:

摘要：

The present disclosure relates to treatment of central nervous system (CNS) cancers (e.g., malignant glioma, glioblastoma, or CNS-multiple myeloma) using marizomib. The disclosure further relates to uses of synergistic combinations of marizomib with additional therapeutic agents such as bevacizumab, daratumumab, temozolomide, pomalidomide, and radiotherapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/